Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

51.8K
Overview
51.8K
What are Viruses?00:50

What are Viruses?

128.3K
Overview
128.3K
Cancer Vaccines01:30

Cancer Vaccines

1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
Tumor Progression02:07

Tumor Progression

7.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.8K
Introduction to Virus01:28

Introduction to Virus

1.7K
Viruses are unique biological entities that blur the boundary between living and non-living systems. Although they lack cellular structure and metabolic processes, they can exhibit characteristics of life when infecting a host. Their defining feature is a nucleic acid core, composed of either DNA or RNA, encapsulated within a protein coat called a capsid. This simple structure allows them to invade host cells and use their machinery for replication efficiently.Viral Structure and...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Iron availability as a time-evolving descriptor linking syntrophic metabolic responses and process performance in nano-iron-amended anaerobic systems.

Bioresource technology·2026
Same author

Clade 2.3.4.4b H5N1 HPAIV from Migratory Birds in Beidaihe Wetland, North China.

Viruses·2026
Same author

Antiviral activity of Saponin C from Liriope muscari against influenza A virus and SARS-CoV-2.

Virologica Sinica·2026
Same author

Marburg Virus Glycoprotein Is a Remarkable Virulent Factor Linked to Hemorrhagic Pathology: Evidence from Multimodal Experimental Systems.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Understanding and Steering the Surface-Pollutant Interaction over Nanoscale Zero-Valent Iron toward Proton-Coupled Electron Transfer.

Langmuir : the ACS journal of surfaces and colloids·2026
Same author

SARS-CoV-2 directly infects the inner ear and causes hearing dysfunction.

Cell reports·2026

Related Experiment Video

Updated: Feb 7, 2026

Rescue and Characterization of Recombinant Virus from a New World Zika Virus Infectious Clone
07:35

Rescue and Characterization of Recombinant Virus from a New World Zika Virus Infectious Clone

Published on: June 7, 2017

10.2K

Zika Virus Vaccine: Progress and Challenges.

Chao Shan1, Xuping Xie1, Pei-Yong Shi1

  • 1Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA; Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 77555, USA; Sealy Center for Structural Biology and Molecular Biophysics, University of Texas Medical Branch, Galveston, TX 77555, USA.

Cell Host & Microbe
|July 17, 2018
PubMed
Summary

An effective Zika virus vaccine is crucial to prevent future epidemics. This review summarizes the current vaccine development pipeline and discusses challenges in clinical trials for Zika virus vaccines.

More Related Videos

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
09:11

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Published on: August 23, 2016

21.4K
Rescue of Recombinant Zika Virus from a Bacterial Artificial Chromosome cDNA Clone
08:10

Rescue of Recombinant Zika Virus from a Bacterial Artificial Chromosome cDNA Clone

Published on: June 24, 2019

27.5K

Related Experiment Videos

Last Updated: Feb 7, 2026

Rescue and Characterization of Recombinant Virus from a New World Zika Virus Infectious Clone
07:35

Rescue and Characterization of Recombinant Virus from a New World Zika Virus Infectious Clone

Published on: June 7, 2017

10.2K
Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
09:11

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Published on: August 23, 2016

21.4K
Rescue of Recombinant Zika Virus from a Bacterial Artificial Chromosome cDNA Clone
08:10

Rescue of Recombinant Zika Virus from a Bacterial Artificial Chromosome cDNA Clone

Published on: June 24, 2019

27.5K

Area of Science:

  • Virology
  • Epidemiology
  • Vaccinology

Background:

  • Zika virus, a mosquito-borne flavivirus, poses significant risks, causing congenital Zika syndrome (microcephaly) in fetuses and Guillain-Barré syndrome in adults.
  • The explosive emergence of Zika virus necessitates urgent development of effective vaccines.
  • Despite a recent decline in reported cases, the threat of future Zika virus epidemics remains.

Purpose of the Study:

  • To provide a comprehensive overview of the current Zika virus vaccine pipeline.
  • To identify and discuss the challenges associated with conducting clinical efficacy trials for Zika virus vaccines.

Main Methods:

  • Literature review of ongoing Zika virus vaccine research and development.
  • Analysis of published data on vaccine candidates and clinical trial designs.

Main Results:

  • Multiple Zika virus vaccine candidates are in various stages of development, utilizing diverse platforms.
  • Key challenges for clinical efficacy trials include ethical considerations, patient recruitment, and defining appropriate endpoints.

Conclusions:

  • An efficacious Zika virus vaccine is urgently needed to mitigate the risk of future epidemics.
  • Overcoming challenges in clinical trial design and execution is critical for successful Zika vaccine deployment.